BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36722625)

  • 1. Psychosocial impact of pediatric alopecia areata: A survey study.
    Benton S; Bellefeuille G; Rypka K; Nguyen A; Raymond O; Gorbatenko-Roth K; Maguiness S; Hordinsky MK
    Pediatr Dermatol; 2023 Mar; 40(2):312-314. PubMed ID: 36722625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
    Barrón-Hernández YL; Tosti A
    Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety.
    Russo PM; Fino E; Mancini C; Mazzetti M; Starace M; Piraccini BM
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):608-611. PubMed ID: 30394586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eyelash alopecia areata: case series and literature review.
    Modjtahedi BS; Kishan AU; Schwab IR; Jackson WB; Maibach HI
    Can J Ophthalmol; 2012 Aug; 47(4):333-8. PubMed ID: 22883840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey.
    Bewley A; Figueras-Nart I; Zhang J; Guerreiro M; Tietz N; Chtourou S; Durand F; Blume-Peytavi U
    Clin Cosmet Investig Dermatol; 2024; 17():751-761. PubMed ID: 38566887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of health utility values for alopecia areata.
    Aggio D; Dixon C; Law EH; Randall R; Price T; Lloyd A
    Qual Life Res; 2024 Jun; 33(6):1581-1592. PubMed ID: 38551802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes F; Dutronc Y; Mesinkovska NA; Ko JM; King BA
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S71-S77. PubMed ID: 33099392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of QOL in Patients with Alopecia Areata.
    Senna M; Ko J; Glashofer M; Walker C; Ball S; Edson-Heredia E; Zhu B; Shapiro J
    J Invest Dermatol; 2022 Oct; 142(10):2646-2650.e3. PubMed ID: 35331716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of disease and quality of life in parents of children with alopecia areata, totalis, and universalis: A prospective, cross-sectional study.
    Putterman E; Patel DP; Andrade G; Harfmann KL; Hogeling M; Cheng CE; Goh C; Rogers RS; Castelo-Soccio L
    J Am Acad Dermatol; 2019 May; 80(5):1389-1394. PubMed ID: 30633941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and physician perspectives on alopecia areata: A real-world assessment of severity and burden in Japan.
    Edson-Heredia E; Aranishi T; Isaka Y; Anderson P; Marwaha S; Piercy J
    J Dermatol; 2022 Jun; 49(6):575-583. PubMed ID: 35343611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan.
    Macey J; Kitchen H; Aldhouse NVJ; Burge RT; Edson-Heredia E; McCollam JS; Isaka Y; Torisu-Itakura H
    Dermatol Ther (Heidelb); 2021 Apr; 11(2):433-447. PubMed ID: 33464474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.
    Macey J; Kitchen H; Aldhouse NVJ; Edson-Heredia E; Burge R; Prakash A; King BA; Mesinkovska N
    Br J Dermatol; 2022 May; 186(5):849-860. PubMed ID: 34811721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
    Am J Clin Dermatol; 2020 Oct; 21(5):725-732. PubMed ID: 32803546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'The psychosocial burden of alopecia areata and androgenetica': a cross-sectional multicentre study among dermatological out-patients in 13 European countries.
    Titeca G; Goudetsidis L; Francq B; Sampogna F; Gieler U; Tomas-Aragones L; Lien L; Jemec GBE; Misery L; Szabo C; Linder D; Evers AWM; Halvorsen JA; Balieva F; Szepietowski J; Romanov D; Marron SE; Altunay IK; Finlay AY; Salek SS; Kupfer J; Dalgard FJ; Poot F
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):406-411. PubMed ID: 31465592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
    ; Moussa A; Bennett M; Wall D; Meah N; York K; Bokhari L; Asfour L; Rees H; Abraham LS; Asz-Sigall D; Basmanav FB; Bergfeld W; Betz RC; Bhoyrul B; Blume-Peytavi U; Callender V; Chitreddy V; Combalia A; Cotsarelis G; Craiglow B; Dhurat R; Donovan J; Doroshkevich A; Eisman S; Farrant P; Ferrando J; Gadzhigoroeva A; Green J; Grimalt R; Harries M; Hordinsky M; Irvine A; Jolliffe V; Kaiumov S; King B; Lee J; Lee WS; Li J; Lortkipanidze N; McMichael A; Mesinkovska NA; Messenger A; Mirmirani P; Olsen E; Orlow SJ; Ovcharenko Y; Piraccini BM; Pirmez R; Rakowska A; Reygagne P; Rudnicka L; Corralo DS; Senna M; Shapiro J; Sharma P; Siliuk T; Starace M; Suchonwanit P; Takwale A; Tosti A; Vañó-Galván S; Visser WI; Vogt A; Wade M; Yip L; Zhou C; Sinclair R
    JAMA Dermatol; 2024 Mar; 160(3):341-350. PubMed ID: 38324292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alopecia areata and diffuse hypotrichosis associated with Ullrich-Turner syndrome. Presentation of 4 patients].
    Tebbe B; Gollnick H; Müller R; Reupke HJ; Orfanos CE
    Hautarzt; 1993 Oct; 44(10):647-52. PubMed ID: 8225974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia.
    Reid EE; Haley AC; Borovicka JH; Rademaker A; West DP; Colavincenzo M; Wickless H
    J Am Acad Dermatol; 2012 Mar; 66(3):e97-102. PubMed ID: 21601948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camouflage technique for alopecia areata: What is a patient to do?
    Draelos ZD
    Dermatol Ther; 2011; 24(3):305-10. PubMed ID: 21689239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.
    Tan E; Tay YK; Goh CL; Chin Giam Y
    Int J Dermatol; 2002 Nov; 41(11):748-53. PubMed ID: 12452996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.